海思科：关于获得创新药HSK39297片新适应症《药物临床试验批准通知书》的公告

Core Viewpoint - Recently, the company received the Clinical Trial Approval Notification from the National Medical Products Administration for its drug HSK39297 tablets [2] Group 1 - The drug HSK39297 has been approved for clinical trials, indicating progress in the company's drug development pipeline [2]